Marimed (MRMD) Non Operating Investment Income (2012 - 2022)
Marimed (MRMD) posted quarterly Non Operating Investment Income of $48000.0 for Q1 2022, up 206.67% year-over-year from $15652.2 in Q1 2021, and up 128.37% quarter-over-quarter from -$169203.0 in Q4 2021.
Marimed (MRMD) Non Operating Investment Income (2012 - 2022) Analysis & Trends
Marimed (MRMD) has reported Non Operating Investment Income for 8 consecutive years, with $48000.0 the latest figure, recorded in Q1 2022.
- In Q1 2022, Non Operating Investment Income rose 206.67% year-over-year to $48000.0; the TTM figure through Mar 2022 stood at -$1.0 million (down 446.63% YoY), while the FY2021 annual figure was -$1.1 million, down 216.5% from the prior year.
- Non Operating Investment Income rose to $48000.0 in Q1 2022 per MRMD's latest filing, from -$169203.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $354534.0 in Q4 2020 and bottomed at -$687002.0 in Q1 2020.
- Historically, Non Operating Investment Income has averaged -$156451.8 across 3 years, with a median of -$169203.0 in 2021.
- Annual changes were most pronounced in 2021 — Non Operating Investment Income plunged 340.19% — and 2022, when it jumped 206.67%.
- Marimed's Non Operating Investment Income stood at $354534.0 in 2020, then plunged by 147.73% to -$169203.0 in 2021, then surged by 128.37% to $48000.0 in 2022.
- Business Quant data shows MRMD's Non Operating Investment Income at $48000.0 in Q1 2022, -$169203.0 in Q4 2021, and -$522106.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Marimed | 28.08 Mn | 17.74 Mn | 16.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 48,000.00 |
| Mar 31, 2022 | 48,000.00 |
| Dec 31, 2021 | -169,203.00 |
| Dec 31, 2021 | -169,203.00 |
| Sep 30, 2021 | -522,106.00 |
| Sep 30, 2021 | -522,106.00 |
| Jun 30, 2021 | -370,119.00 |
| Jun 30, 2021 | -370,119.00 |
| Mar 31, 2021 | -45,000.00 |
| Mar 31, 2021 | -45,000.00 |
| Dec 31, 2020 | 354,534.00 |
| Dec 31, 2020 | 354,534.00 |
| Sep 30, 2020 | 217,374.00 |
| Sep 30, 2020 | 217,374.00 |
| Jun 30, 2020 | -234,544.00 |
| Jun 30, 2020 | -234,544.00 |
| Mar 31, 2020 | -687,002.00 |
| Mar 31, 2020 | -687,002.00 |
| Dec 31, 2016 | -536.00 |
| Dec 31, 2016 | -536.00 |